Anemia Market Research
Anemia, one of the more common blood disorders, occurs when the level of healthy red blood cells (RBCs) in the body reduces considerably. This can cause health problems because RBCs contain hemoglobin, which carries oxygen to the body's tissues. Anemia may result in a variety of complications, including fatigue and stress on bodily organs.
The Anemia market research report is an essential source of information and analysis on the global Anemia market. The report identifies the key trends shaping and driving the global Anemia market. In 2007, safety concerns over the use of ESAs (Erythropoietin Stimulating Agents) surfaced and this resulted in a decline in sales of the drugs. Since then, growth in the anemia market has been declining. Between 2009 and 2017, the market is expected to decline further as there are no key promising therapies expected to enter the anemia market.
The research further goes on to provide insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.
